Letter to the Editor

The High Prevalence of Osteoporosis as a Preventable Disease: The Need for Greater Attention to Prevention Programs in Iran

Abstract

The High Prevalence of Osteoporosis as a Preventable Disease: The Need for Greater Attention to Prevention Programs in Iran

Cosman F, de Beur SJ, LeBoff MS et al (2014). Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int, 25:2359-81.

Doosti Irani A, Poorolajal J, Khalilian A et al (2013). Prevalence of osteoporosis in Iran: A meta-analysis. J Res Med Sci, 18:759-66.

El-Hajj Fuleihan G, Adib G, Nauroy L (2011). The middle east & Africa regional audit, epidemiology, costs & burden of osteoporosis in 2011. International Osteoporosis Foundation, Switzerland pp. 102011-105000.

WHO Iran (Islamic Republic of): WHO statistical profile. http://www.who.int/countries/irn/en/

Institute for Health Metrics and Evaluation Iran: How long do people live? http://www.healthdata.org/iran

IRNA Iran’s per capita milk consumption. http://www.irna.ir/en/News/2716240/Social/Iran%E2%80%99s_per_capita_milk_consumption

Hashemipour S, Larijani B, Adibi H et al (2004). Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health, 4:38.

Hovsepian S, Amini M, Aminorroaya A et al (2011). Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. J Health Popul Nutr, 29:149-55.

Moussavi M, Heidarpour R, Aminorroaya A et al (2005). Prevalence of vitamin D deficiency in Isfahani high school students in 2004. Horm Res, 64:144-8.

Files
IssueVol 47 No 8 (2018) QRcode
SectionLetter to the Editor
Keywords
No keywords####

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
DOOSTI-IRANI A, GHAFARI M, CHERAGHI Z. The High Prevalence of Osteoporosis as a Preventable Disease: The Need for Greater Attention to Prevention Programs in Iran. Iran J Public Health. 2018;47(8):1220-1221.